Boardroom Alpha
Boardroom Alpha
CBRE · Current Report (Form 8-K) · Filed June 23, 2026

Cbre Group Inc — Current Report (Form 8-K)

Form
8-K
Filed
June 23, 2026
Period
Jun 23, 2026
Ticker
CBRE
Accession
0001193125-26-279756
Boardroom Alpha · Filing insights

CBRE enters a 364-day, $1B unsecured revolver for CBRE Services with standard terms and a 2027 maturity.

About Cbre Group Inc
Market cap
$43.7B
1Y TSR
−5.7%
3Y TSR
+21.4%
Board grade
B
Sector
Real Estate
CEO
Robert E Sulentic
Last annual meeting: May 21, 2026 · View full Cbre Group Inc profile →
8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 23, 2026

CBRE GROUP, INC.

(Exact name of Registrant as Specified in Its Charter)

Delaware

001-32205

94-3391143

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

 

 

2121 North Pearl Street

Suite 300

Dallas, Texas

75201

(Address of Principal Executive Offices)

(Zip Code)

(214) 979-6100

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Class A Common Stock, $0.01 par value per share

 

CBRE

 

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


 

This Current Report on Form 8-K is filed by CBRE Group, Inc., a Delaware corporation (the “Company”), in connection with the matters described herein.

Item 1.01 Entry into a Material Definitive Agreement.

364-Day Revolving Credit Agreement

On June 23, 2026, the Company entered into a new 364-day senior unsecured Revolving Credit Agreement (the “364-Day Revolving Credit Agreement”), by and among the Company, CBRE Services, Inc., a Delaware corporation (“Services”), the lenders party thereto and Wells Fargo Bank, National Association (“Wells Fargo”), as administrative agent for the lenders. The 364-Day Revolving Credit Agreement provides for a senior unsecured revolving credit facility available to Services with commitments in an aggregate principal amount of up to $1 billion. The 364-Day Revolving Credit Agreement replaces the Company’s previous 364-day senior unsecured Revolving Credit Agreement, dated as of June 24, 2025, which was scheduled to terminate on June 23, 2026.

Interest Rate and Fees

The 364-Day Revolving Credit Agreement provides that loans will bear interest at (i) a rate equal to an applicable rate (as described below), plus, (ii) at Services’ option, either (a) a Term SOFR rate published by CME Group Benchmark Administration Limited for the applicable interest period or (b) a base rate determined by reference to the greatest of (1) the prime rate determined by Wells Fargo, (2) the federal funds rate plus 1/2 of 1% and (3) the sum of (x) a Term SOFR rate published by CME Group Benchmark Administration Limited for an interest period of one month and (y) 1.00%.

The applicable rate for borrowings under the 364-Day Revolving Credit Agreement will generally bear interest at an annual rate equal to Term SOFR plus between 0.645% and 1.125%, depending on the Company’s credit rating.

The base rate spread for borrowings under the 364-Day Revolving Credit Agreement will generally bear interest at a rate between 0% and 0.10%, depending on the Company’s credit rating. In addition to paying interest on outstanding principal under the 364-Day Revolving Credit Agreement, Services is required to pay a facility fee of between 0.055% and 0.125% to the lenders under the 364-Day Revolving Credit Agreement (whether drawn or undrawn), which facility fee is based on the Company’s credit rating.

Prepayments

The 364-Day Revolving Credit Agreement does not require Services to prepay revolving loans under the 364-Day Revolving Credit Agreement (“364-Day Revolving Credit Loans”), except on any date on which the sum of all outstanding 364-Day Revolving Credit Loans exceed the Revolving Credit Commitment under the 364-Day Revolving Credit Agreement, in which case Services must pay 100% of such excess amount.

Services may voluntarily repay 364-Day Revolving Credit Loans at any time, in whole or in part, without premium or penalty (other than customary “breakage” costs). In addition, Services may elect to permanently terminate or reduce all or a portion of the Revolving Credit Commitments under the 364-Day Revolving Credit Agreement, in each case, without premium or penalty.

Maturity

The entire principal amount of the 364-Day Revolving Credit Loans (if any) is due and payable in full at maturity on June 22, 2027, on which day the Revolving Credit Commitments under the 364-Day Revolving Credit Agreement will terminate.

Guarantee

All obligations under the 364-Day Revolving Credit Agreement are guaranteed by the Company, Services (solely with respect to certain guaranteed subsidiary cash management and hedging obligations) and each of the Company’s

 


 

direct and indirect U.S. wholly-owned subsidiaries which guarantee any other material indebtedness of the Company and its subsidiaries. As of the date hereof, no such subsidiaries guarantee the 364-Day Revolving Credit Agreement or any other material indebtedness of the Company and its subsidiaries.

Covenants and Events of Default

 

The 364-Day Revolving Credit Agreement includes a financial covenant requiring the Company and its subsidiaries to maintain a specified maximum leverage ratio on the last day of each fiscal quarter. In addition, the 364-Day Revolving Credit Agreement also contains other customary affirmative and negative covenants and events of default.

 

Unless otherwise defined in the forgoing descriptions, capitalized terms shall have the meaning set forth in the 364-Day Revolving Credit Agreement. The foregoing description of the 364-Day Revolving Credit Agreement is not complete and is qualified in its entirety by the terms and provisions of the 364-Day Revolving Credit Agreement and the Guaranty Agreement, copies of which are filed herewith as Exhibits 10.1 and 10.2, respectively, to this Current Report on Form 8-K, which are incorporated herein by reference.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The information set forth under Item 1.01 of this Current Report on Form 8-K is hereby incorporated by reference into this Item 2.03.

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.

Exhibit Description

 

 

10.1*

364-Day Revolving Credit Agreement, dated as of June 23, 2026, among CBRE Group, Inc., CBRE Services, Inc., the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent.

 

 

 

10.2

Guaranty Agreement, dated as of June 23, 2026, among CBRE Group, Inc., CBRE Services, Inc. and Wells Fargo Bank, National Association, as administrative agent.

 

 

 

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

*Certain of the schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Company agrees to provide a copy of all omitted schedules to the Securities and Exchange Commission or its staff upon its request.

 

 


 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date: June 23, 2026

CBRE GROUP, INC.

 

 

 

 

 

 

By:

/s/ EMMA E. GIAMARTINO

 

 

 

Emma E. Giamartino

 

 

 

Chief Financial Officer and Chief Investment Officer

 

 


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Cbre Group Inc (CBRE)

Reference

Frequently asked questions

When did Cbre Group Inc file this 8-K?
Cbre Group Inc (CBRE) filed this Current Report (Form 8-K) with the SEC on June 23, 2026. The accession number assigned by EDGAR is 0001193125-26-279756.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
CBRE enters a 364-day, $1B unsecured revolver for CBRE Services with standard terms and a 2027 maturity. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Cbre Group Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Cbre Group Inc has filed under CIK 1138118, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer